Skip to main content
Top
Published in: Infection 6/2010

01-12-2010 | Correspondence

Post varicella disseminated intravascular coagulation and transient protein S deficiency in an otherwise healthy 6-year-old boy: a case report

Authors: V. Wiegering, G. Balling, J. Wirbelauer, A. Sturm, H. J. Girschick

Published in: Infection | Issue 6/2010

Login to get access

Excerpt

Varicella infections are usually considered to be benign, even though varicella disease may cause serious complications. However, in Europe, the incidence of varicella infections (and complications) has been reported to peak in the spring [1]. An increased risk of complications is well known in immunocompromised individuals and in neonates, if maternal varicella has erupted close to birth. Severe complications (0.82/100,000 children/year) can also occur in previously healthy children, including central nervous system manifestations (61%), secondary bacterial infections (38%), haematological disorders (5%) and occasional fatal outcome (6%) [1, 2]. Purpura fulminans is a thrombotic disease that can occur during infections, disseminated intravascular coagulation (DIC) or in the context of an acquired or congenital protein C or S deficiency. The importance of protein S and C as two inhibitors in haemostasis is well known because severe inherited deficiency is associated with neonatal purpura fulminans and heterozygous protein S or C deficiency is associated with venous thromboembolism. …
Literature
1.
go back to reference Cameron JC, Allan G, Johnston F, Finn A, Heath PT, Booy R. Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child. 2007;92:1062–6.CrossRefPubMed Cameron JC, Allan G, Johnston F, Finn A, Heath PT, Booy R. Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child. 2007;92:1062–6.CrossRefPubMed
2.
go back to reference Gershon AA, Hambleton S. Varicella vaccine for susceptible adults: do it today. Clin Infect Dis. 2004;39:1640–1.CrossRefPubMed Gershon AA, Hambleton S. Varicella vaccine for susceptible adults: do it today. Clin Infect Dis. 2004;39:1640–1.CrossRefPubMed
3.
go back to reference Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics. 2001;108:E79.CrossRefPubMed Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ. Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics. 2001;108:E79.CrossRefPubMed
4.
go back to reference Kayemba Kay’s S, François P, Pollack B, Moutet F, Cussac E, Bost M. Localized thrombotic purpura: a rare complication of chickenpox. J Pediatr. 1997;130:655–7.CrossRef Kayemba Kay’s S, François P, Pollack B, Moutet F, Cussac E, Bost M. Localized thrombotic purpura: a rare complication of chickenpox. J Pediatr. 1997;130:655–7.CrossRef
5.
go back to reference Campanelli A, Kaya G, Ozsahin AH, La Scala G, Jacquier C, Stauffer M, et al. Purpura fulminans in a child as a complication of chickenpox infection. Dermatology. 2004;208:262–4.CrossRefPubMed Campanelli A, Kaya G, Ozsahin AH, La Scala G, Jacquier C, Stauffer M, et al. Purpura fulminans in a child as a complication of chickenpox infection. Dermatology. 2004;208:262–4.CrossRefPubMed
7.
go back to reference Abdulmalik A, Al-Ateeqi W, Al-Khawari M, Al-Osaimi S. Varicella-associated purpura fulminans: chicken pox is not always benign. Med Princ Pract. 2006;15:232–4.CrossRefPubMed Abdulmalik A, Al-Ateeqi W, Al-Khawari M, Al-Osaimi S. Varicella-associated purpura fulminans: chicken pox is not always benign. Med Princ Pract. 2006;15:232–4.CrossRefPubMed
8.
go back to reference Heeb MJ, España F, Griffin JH. Inhibition and complexation of activated protein C by two major inhibitors in plasma. Blood. 1989;73:446–54.PubMed Heeb MJ, España F, Griffin JH. Inhibition and complexation of activated protein C by two major inhibitors in plasma. Blood. 1989;73:446–54.PubMed
9.
go back to reference Heeb MJ, Mosher D, Griffin JH. Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation. Blood. 1989;73(2):455–61.PubMed Heeb MJ, Mosher D, Griffin JH. Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation. Blood. 1989;73(2):455–61.PubMed
10.
go back to reference Josephson C, Nuss R, Jacobson L, Hacker MR, Murphy J, Weinberg A, et al. The varicella-autoantibody syndrome. Pediatr Res. 2001;50(3):345–52.CrossRefPubMed Josephson C, Nuss R, Jacobson L, Hacker MR, Murphy J, Weinberg A, et al. The varicella-autoantibody syndrome. Pediatr Res. 2001;50(3):345–52.CrossRefPubMed
11.
go back to reference Kurugöl Z, Vardar F, Ozkinay F, Kavakli K, Ozkinay C. Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infection. Acta Paediatr. 2000;89:1186–9.CrossRefPubMed Kurugöl Z, Vardar F, Ozkinay F, Kavakli K, Ozkinay C. Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infection. Acta Paediatr. 2000;89:1186–9.CrossRefPubMed
12.
go back to reference Levin M, Eley BS, Louis J, Cohen H, Young L, Heyderman RS. Postinfectious purpura fulminans caused by an autoantibody directed against protein S. J Pediatr. 1995;127:355–63.CrossRefPubMed Levin M, Eley BS, Louis J, Cohen H, Young L, Heyderman RS. Postinfectious purpura fulminans caused by an autoantibody directed against protein S. J Pediatr. 1995;127:355–63.CrossRefPubMed
13.
go back to reference Manco-Johnson MJ, Nuss R, Key N, Moertel C, Jacobson L, Meech S, et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr. 1996;128:319–23.CrossRefPubMed Manco-Johnson MJ, Nuss R, Key N, Moertel C, Jacobson L, Meech S, et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr. 1996;128:319–23.CrossRefPubMed
14.
go back to reference Regnault V, Boehlen F, Ozsahin H, Wahl D, de Groot PG, Lecompte T, et al. Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation. J Thromb Haemost. 2005;3:1243–9.CrossRefPubMed Regnault V, Boehlen F, Ozsahin H, Wahl D, de Groot PG, Lecompte T, et al. Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation. J Thromb Haemost. 2005;3:1243–9.CrossRefPubMed
15.
go back to reference Sorice M, Griggi T, Circella A, Lenti L, Arcieri P, Domenico di Nucci G, et al. Protein S antibodies in acquired protein S deficiencies. Blood. 1994;83:2383–4.PubMed Sorice M, Griggi T, Circella A, Lenti L, Arcieri P, Domenico di Nucci G, et al. Protein S antibodies in acquired protein S deficiencies. Blood. 1994;83:2383–4.PubMed
16.
go back to reference Bergmann F, Hoyer PF, D’Angelo SV, Mazzola G, Oestereich C, Barthels M, et al. Severe autoimmune protein S deficiency in a boy with idiopathic purpura fulminans. Br J Haematol. 1995;89:610–4.CrossRefPubMed Bergmann F, Hoyer PF, D’Angelo SV, Mazzola G, Oestereich C, Barthels M, et al. Severe autoimmune protein S deficiency in a boy with idiopathic purpura fulminans. Br J Haematol. 1995;89:610–4.CrossRefPubMed
Metadata
Title
Post varicella disseminated intravascular coagulation and transient protein S deficiency in an otherwise healthy 6-year-old boy: a case report
Authors
V. Wiegering
G. Balling
J. Wirbelauer
A. Sturm
H. J. Girschick
Publication date
01-12-2010
Publisher
Urban and Vogel
Published in
Infection / Issue 6/2010
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-010-0053-9

Other articles of this Issue 6/2010

Infection 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine